National Sciences Academy Asks Court to Strip Sackler Name From Endowment
The New York Times
Millions in Sackler donations sat dormant, rising in value as the opioid epidemic raged and as other institutions distanced themselves from the makers of a notorious painkiller.
The National Academy of Sciences is asking a court to allow it to repurpose about $30 million in donations from the wealthy Sackler family, who controlled the company at the center of the opioid epidemic, and to remove the family name from the endowment funds.
The petition filed by the Academy in Superior Court in Washington, D.C., Thursday aims to modify the terms of the donations so the institution can use them for scientific studies, projects and educational activities.
The move follows a report in The New York Times last year that examined donations from several Sackler members, including an executive of Purdue Pharma, which produced the painkiller OxyContin that has long been blamed for fueling the opioid crisis that has claimed thousands of lives.
“The notoriety of the Sackler name has made it impossible for the Academy to carry out the purposes for which it originally accepted the funds,” Marcia McNutt, president of the National Academy of Sciences, said in a statement released on Thursday.
Daniel S. Connolly, a spokesman for the Raymond Sackler family, said it supported the National Academies in “using the funds as they see fit” and would have supported the change.
“We would have said yes if we’d been asked, just as we will still say yes despite this unnecessary court filing and false assertions about us,” Mr. Connolly said in a statement.
New findings suggest that an extraordinarily powerful and dangerous burst of radiation might flare from our sun in the future.
Anchored by juicy braised duck and finished with an unforgettable family-size crème brûlée, this menu from Clare de Boer will have everyone talking.
The shower forms from the debris of an asteroid and peaks this weekend. But a nearly full moon could interfere with viewing.
The opposing paths taken by two powerful firms — Benchmark and Andreessen Horowitz — embody a profound debate about the future of an industry that funds and fosters American innovation.
Aaron Siri, who specializes in vaccine lawsuits, has been at Robert F. Kennedy Jr.’s side reviewing candidates for top jobs at the Department of Health and Human Services.
Scientists are concerned that the H5N1 virus could set off another human pandemic. But it is already putting species under pressure in the wild.
The scarcity and fragility of rare old bottles makes them naturally memorable, but these 12 younger wines had their own unforgettable charms.
DNA from European fossils dating back 45,000 years offers new clues to how our species spread across the world.
An intense struggle has unfolded in Washington between companies and officials over where to draw the line on selling technology to China.
There’s a universal — and easy — answer to a common kitchen predicament.
More adolescents than ever are watching it. What’s needed, researchers say, are frank conversations and “porn literacy.”